Figure 1
Figure 1. Cumulative probability of progression to symptomatic WM requiring therapy, amyloidosis, or lymphoma in the cohort of 48 patients with SWM.

Cumulative probability of progression to symptomatic WM requiring therapy, amyloidosis, or lymphoma in the cohort of 48 patients with SWM.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal